Developing new antibiotics using single-cell technology
A single-cell approach to developing non-traditional antibiotics
['FUNDING_OTHER'] · PRINCETON UNIVERSITY · NIH-10923339
This study is all about finding new antibiotics to help fight stubborn bacterial infections that don't respond to current treatments, using a special technique to see how bacteria and our cells interact, which could lead to better ways to tackle these tough germs.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | PRINCETON UNIVERSITY (nih funded) |
| Locations | 1 site (Princeton, UNITED STATES) |
| Trial ID | NIH-10923339 on ClinicalTrials.gov |
What this research studies
This research focuses on creating innovative antibiotics to combat bacterial infections, particularly those that have developed resistance to existing treatments. By utilizing a cutting-edge single-cell RNA-sequencing method called M3-Seq, researchers can analyze the interactions between bacteria and host cells at an unprecedented level of detail. This approach allows for the simultaneous monitoring of gene expression in both bacterial and human cells, providing insights that traditional methods cannot achieve. The goal is to identify novel mechanisms of action for antibiotics that can effectively target resistant bacteria.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from bacterial infections, particularly those caused by antibiotic-resistant strains.
Not a fit: Patients with viral infections or those who do not have bacterial infections may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new antibiotics that effectively treat resistant bacterial infections.
How similar studies have performed: Other research has shown promise in using advanced sequencing technologies to understand bacterial resistance, indicating that this approach could yield significant advancements.
Where this research is happening
Princeton, UNITED STATES
- PRINCETON UNIVERSITY — Princeton, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: GITAI, ZEMER — PRINCETON UNIVERSITY
- Study coordinator: GITAI, ZEMER
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Bacterial Infections